Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon Apr 04, 2017 12:05pm
125 Views
Post# 26073502

RE:RE:RE:RE:RE:Trial details

RE:RE:RE:RE:RE:Trial details
LaserStock29 wrote:
Mickey2 wrote: I believe the safety of this trial is vital now.  If you listen to the interview that laserstock29 posted, the previous trial with the older PDT drugs, it killed the cancer, but failed on safety, 



First CT Tissue scan is in 25 days... we'll have a very good idea of how this works on bladder tissue

If I was to think this out...... Echelon is probably right on the sidelines awaiting the safety results before recommending this officially.

I mean the doctors have to know what the reaction is on the bladder wall and that takes a bit of time. 

But gentleman did you expect to wake up today and have 1 patient treated with 2 more right in queue?

I certaintly didn't... and the wine got opened in the am. 

Have a great day, listen to the podcast with the good doctor... know we're OFFICIALLY an ONCOLOGY company

and oh yeah.... October 28 + 6 months is April 28th for Dr.Mandel GBM Phase 1b filing for Brain Cancer (probably 1-2wk of May becuase of holidays)  

So it's timed out to coincide..... our pdt is safe followed by more indications.


LOVE IT




Great post.
Bullboard Posts